Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
Placental Growth Factor Mediates Crosstalk Between Lung Cancer Cells and Tumor-Associated Macrophages in Controlling Cancer Vascularization and Growth. [electronic resource] by
- He, Changjun
- Zhu, Kaibin
- Bai, Xue
- Li, Yingbin
- Sun, Dawei
- Lang, Yaoguo
- Ning, Jinfeng
- Sun, Fenglin
- Qu, Changfa
- Xu, Shidong
Producer: 20180817
In:
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology vol. 47
Availability: No items available.
|
|
11.
|
Downregulating hypoxia-inducible factor-2α improves the efficacy of doxorubicin in the treatment of hepatocellular carcinoma. [electronic resource] by
- He, Changjun
- Sun, Xue-Pu
- Qiao, Haiquan
- Jiang, Xian
- Wang, Dongdong
- Jin, Xiangguo
- Dong, Xuesong
- Wang, Jizhou
- Jiang, Hongchi
- Sun, Xueying
Producer: 20120416
In:
Cancer science vol. 103
Availability: No items available.
|
|
12.
|
LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells. [electronic resource] by
- Li, Weidong
- Dong, Xuesong
- He, Changjun
- Tan, Gang
- Li, Ziyi
- Zhai, Bo
- Feng, Jing
- Jiang, Xian
- Liu, Chang
- Jiang, Hongchi
- Sun, Xueying
Producer: 20190904
In:
Journal of experimental & clinical cancer research : CR vol. 38
Availability: No items available.
|
|
13.
|
Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells. [electronic resource] by
- Zhao, Dali
- Zhai, Bo
- He, Changjun
- Tan, Gang
- Jiang, Xian
- Pan, Shangha
- Dong, Xuesong
- Wei, Zheng
- Ma, Lixin
- Qiao, Haiquan
- Jiang, Hongchi
- Sun, Xueying
Producer: 20141104
In:
Cellular signalling vol. 26
Availability: No items available.
|